What is the recommended antibiotic for cat scratch disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotic Treatment for Cat Scratch Disease

Azithromycin is the recommended first-line antibiotic treatment for cat scratch disease, with a dosage of 500 mg on day 1 followed by 250 mg for 4 additional days for patients >45 kg, or 10 mg/kg on day 1 and 5 mg/kg for 4 more days for patients <45 kg. 1

Treatment Algorithm

First-line Treatment:

  • Azithromycin:
    • Adults/patients >45 kg: 500 mg on day 1, then 250 mg daily for 4 days
    • Children/patients <45 kg: 10 mg/kg on day 1, then 5 mg/kg daily for 4 days

Alternative Treatments:

  1. Erythromycin: 500 mg four times daily for 2 weeks to 2 months 1
  2. Doxycycline: 100 mg twice daily for 2 weeks to 2 months 1
  3. Ciprofloxacin: Has shown clinical efficacy 2
  4. Trimethoprim-sulfamethoxazole: Effective option, particularly for complicated cases 2

Special Considerations

For Complicated Infections:

  • CNS involvement: Doxycycline with or without rifampin 1
  • Immunocompromised patients: Extended treatment courses (>3 months) 1
  • Diabetic patients: Amoxicillin-clavulanate 875/125 mg orally twice daily for 5-7 days 1

For Cat Bites/Scratches (Initial Prophylaxis):

  • Amoxicillin-clavulanate: 875/125 mg twice daily 1
  • For penicillin-allergic patients: Doxycycline 100 mg twice daily 1

Clinical Context

Cat scratch disease is caused by Bartonella henselae and typically presents with regional lymphadenopathy developing approximately 3 weeks after inoculation. A papule or pustule appears at the site of scratch/bite 3-30 days after exposure 1. While many cases are self-limited and may not require antibiotic treatment 3, treatment is recommended for:

  • Severe or persistent symptoms
  • Immunocompromised patients
  • Disseminated disease
  • Ocular involvement
  • Neurologic manifestations

Evidence Quality and Considerations

The recommendation for azithromycin as first-line therapy is supported by the highest quality evidence. In a placebo-controlled study, azithromycin therapy was associated with more rapid reduction in size of infected lymph nodes 2. This aligns with more recent guidelines that rate the evidence for azithromycin as moderate to high 1.

It's important to note that lymphadenopathy may persist for 1-6 months despite appropriate treatment 1. Clinical reassessment within 24-48 hours is necessary for patients with worsening lymphangitis and edema.

Common Pitfalls to Avoid

  1. Delayed diagnosis: Serology is the primary diagnostic method, but antibodies may not be detectable for up to 6 weeks after infection 1

  2. Inadequate treatment duration: For complicated cases, especially in immunocompromised patients, treatment should be extended (minimum 3 months) 1

  3. Overlooking prevention: Advise patients (especially immunocompromised) to:

    • Avoid rough play with cats
    • Keep cats' nails trimmed
    • Implement proper flea control
    • Wash hands thoroughly after handling cats 1
  4. Missing atypical presentations: Cat scratch disease can present as Parinaud oculoglandular syndrome, neuroretinitis, persistent fever, hepatosplenic infection, encephalopathy, or osteomyelitis 2

References

Guideline

Cat Ownership and Immunocompromised Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of cat-scratch disease.

Current opinion in pediatrics, 2001

Research

Cat-scratch Disease.

American family physician, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.